Artificial neural network models for early diagnosis of hepatocellular carcinoma using serum levels of &#x03B1;-fetoprotein, &#x03B1;-fetoprotein-L3, des-&#x03B3;-carboxy prothrombin, and Golgi protein 73

Bo Li; Boan Li; Tongsheng Guo; Zhiqiang Sun; Xiaohan Li; Xiaoxi Li; Lin Chen; Jing Zhao; Yuanli Mao

doi:10.18632/oncotarget.19298

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Artificial neural network models for early diagnosis of hepatocellular carcinoma using serum levels of α-fetoprotein, α-fetoprotein-L3, des-γ-carboxy prothrombin, and Golgi protein 73

Bo Li, Boan Li, Tongsheng Guo, Zhiqiang Sun, Xiaohan Li, Xiaoxi Li, Lin Chen, Jing Zhao and Yuanli Mao _

PDF | HTML | How to cite

Oncotarget. 2017; 8:80521-80530. https://doi.org/10.18632/oncotarget.19298

Metrics: PDF 1631 views | HTML 2594 views | ?

Abstract

Bo Li1,*, Boan Li1,*, Tongsheng Guo1, Zhiqiang Sun1, Xiaohan Li1,2, Xiaoxi Li1, Lin Chen1,2, Jing Zhao1 and Yuanli Mao1,2

1Center for Clinical Laboratory, 302 Millitary Hospital, Beijing, China

2Graduate student team, Medical University of PLA, Beijing, China

*These authors contributed equally to this work

Correspondence to:

Yuanli Mao, email: [email protected]

Keywords: hepatocellular carcinoma, artificial neural network, serum tumor biomarker

Received: April 07, 2017 Accepted: June 02, 2017 Published: July 17, 2017

ABSTRACT

More than 70% of hepatocellular carcinoma (HCC) cases develop as a consequence of liver cirrhosis (LC). Here we have evaluated the diagnostic potential of four serum biomarkers, and developed models for HCC diagnosis and differentiation from LC patients. Serum levels of α-fetoprotein (AFP), AFP-L3, des-γ-carboxy prothrombin (DCP), and Golgi protein 73 (GP73) were analyzed in 114 advanced HCC patients, 81 early stage HCC patients, and 152 LC patients. Multilayer perceptron (MLP) and radial basis function (RBF) neural networks were used to construct the diagnostic models. Using all stages, HCC diagnostic models had a higher sensitivity (>70%) than the individual serum biomarkers, whereas only early stage HCC diagnostic models had a higher specificity (>80%). The early stage HCC diagnostic models could not be used as HCC screening tools due to their low sensitivity (about 40%). These results suggest that a combination of the two models might be used as a screening tool to distinguish early stage HCC patients from LC patients, thus improving prevention and treatment of HCC.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 19298

Publication Alerts

Research Papers:

Artificial neural network models for early diagnosis of hepatocellular carcinoma using serum levels of α-fetoprotein, α-fetoprotein-L3, des-γ-carboxy prothrombin, and Golgi protein 73

Abstract